Acta Pharmacologica Sinica 2008 December; 29 (12): 1499-1506; doi: 10.1111/j.1745-7254.2008.00898.x

 
Original Article
[ Full text]
 
Quantitative determination of acetylshikonin in macaque monkey blood by LC-ESI-MS/MS after precolumn derivatization with 2-mercaptoethanol and its application in pharmacokinetic study1
 

Dong-xiao SUN2, Hui-fang TIAN2,3, Zhi-yun MENG2, Alicia DU4, Dan YUAN3, Ruo-lan GU3, Zhuo-na WU3, Gui-fang DOU2,5

2Laboratory of Drug Metabolism and Pharmacokinetics, Beijing Institute of Transfusion Medicine, Beijing 100850, China; 3School of Chinese Traditional Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China; 4ThermoFisher Scientific, San Jose, California, USA

 

Aim: To develop and validate a novel precolumn derivatization method for the quantitative determination and pharmacokinetic application of acetylshikonin in macaque monkeys by liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS).

 

Methods: 2-Mercaptoethanol was added to the blood sample as the derivatization reagent. The derivatization reaction formed 1 major derivation product, which was well correlated with acetylshikonin. The acetylshikonin concentrations in the biological samples were calculated by quantitative determination of the major derivation product using LC-ESI-MS/MS. Separation was achieved using a C18 column (2 mm×50 mm, 5 μm) at room temperature and a linear gradient elution with a mobile phase containing methanol (1.96% acetic acid) and 10% methanol in water (1.96% acetic acid and 10 mmol/L ammonium acetate) at a flow rate of 0.2 mL/min. In addition, the major derivative, named derivative III, was identified by UV spectra, MS, and the 1H-NMR and 13C-NMR spectra.

 

Results: Good linearity was obtained within the range of 5 and 2000 ng/mL (r>0.99 using a linear regression model with 1/x2 weighting) for acetylshikonin. The interday and intraday precisions were found to be less than 12.3%, with the exception of the lowest concentration, which was less than 17.2%. The interday and intraday accuracies, which were between _3% and 0.6%, were also observed. After the administration of acetylshikonin (80 mg/kg, po) in macaque monkeys, the pharmacokinetic parameters were obtained through the non-compartmental analysis, where the area under the concentration-time curve to the last measurable concentration, the terminal elimination half-life, and the mean residual time were 615.4±206.5 ng·h/mL,12.3±1.6 h, and 10.2±0.7 h, respectively.


Conclusion:
The method was validated and applied to the quantitative determination and pharmacokinetic study of acetylshikonin in the blood samples of macaque monkeys.

 

Keywords: acetylshikonin; macaque monkey blood; liquid chromatography-electrospray ionization tandem mass spectrometry; 2-mercaptoethanol; precolumn derivatization; pharmacokinetic

 

1 This work was supported by Beijing Jin BenCao Chinese Herbal Medicine Technology Development.

5 Correspondence to Prof Gui-fang DOU.
Phn/Fax 86-10-6693-2951.
E-mail douguifang@vip.163.com
Received 2008-05-06     Accepted 2008-09-12

[ Full text]
 

Copyright©APS 2009
Add: 294 Tai-Yuan Road, Shanghai 200031, China
Phn: 86-21-5492-2821  Fax: 86-21-5492-2823
E-mail: aps@mail.shcnc.ac.cn